Wednesday, December 06, 2023 4:54:53 PM
There is no JAN 25 call date in 2024. there is only DEC 15 & JAN 19 2024 CALL dates:
Here is the Jan 19 2024 call dates:
JAN 19 2024 AMRN
CALLS PUTS
Open Interest Tot. Volume $ Chg. Close Theoretical Value Last Trade Bid Ask Strike Price Bid Ask Last Trade Theoretical Value $ Chg. Close Tot. Volume Open Interest
161 2 0.01 0.38 0.35 0.20 0.55 0.50 0.00 0.10 0.04 0.0 0.00 0.00
2319 973 0.05 0.08 0.07 0.05 0.10 1.00 0.20 0.30 0.25 0.25 -0.05 86.00 1006.00
10770 0 0 0.03 0.01 0.00 0.05 1.50 0.35 1.50 0.70 0.93 0.00 0.00 222.00
3904 0 0 0.03 0.02 0.00 0.05 2.00 0.90 1.95 1.35 1.43 0.00 0.00 1.00
787 0 0 0.03 0.05 0.00 0.05 2.50 1.00 2.55 0.00 1.77 n/a 0.00 0.00
3132 0 0 0.03 0.04 0.00 0.05 3.00 1.50 3.00 2.29 2.25 0.00 0.00 17.00
62 0 0 0.03 0.01 0.00 0.05 3.50 2.10 4.00 0.00 3.05 n/a 0.00 0.00
Here is the Jan 19 2024 call dates:
JAN 19 2024 AMRN
CALLS PUTS
Open Interest Tot. Volume $ Chg. Close Theoretical Value Last Trade Bid Ask Strike Price Bid Ask Last Trade Theoretical Value $ Chg. Close Tot. Volume Open Interest
161 2 0.01 0.38 0.35 0.20 0.55 0.50 0.00 0.10 0.04 0.0 0.00 0.00
2319 973 0.05 0.08 0.07 0.05 0.10 1.00 0.20 0.30 0.25 0.25 -0.05 86.00 1006.00
10770 0 0 0.03 0.01 0.00 0.05 1.50 0.35 1.50 0.70 0.93 0.00 0.00 222.00
3904 0 0 0.03 0.02 0.00 0.05 2.00 0.90 1.95 1.35 1.43 0.00 0.00 1.00
787 0 0 0.03 0.05 0.00 0.05 2.50 1.00 2.55 0.00 1.77 n/a 0.00 0.00
3132 0 0 0.03 0.04 0.00 0.05 3.00 1.50 3.00 2.29 2.25 0.00 0.00 17.00
62 0 0 0.03 0.01 0.00 0.05 3.50 2.10 4.00 0.00 3.05 n/a 0.00 0.00
Recent AMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
